GTR Home > Tests > Gastrointestinal stromal tumor

Overview

Test name

Help

Gastrointestinal stromal tumor (GIST)

Purpose of the test

Help

This is a clinical test intended for Help: Diagnosis, Drug Response

Condition

Help

1 condition tested. Click Indication tab for more information.

Methodology

Help
Molecular Genetics
ESequence analysis of select exons
Bi-directional Sanger Sequence Analysis
  • Applied Biosystems 3130XL
CSequence analysis of the entire coding region
Bi-directional Sanger Sequence Analysis
  • Applied Biosystems 3130XL

Summary of what is tested

2 genes and variants. Click Methodology tab for more information.

Genes

Clinical validity

Help

Not provided

Clinical utility

Help

Not provided

How to order

Help

Not provided

Practice guidelines

  • ACMG/NSGC, 2015
    A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
  • EGTM, 2014
    Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update.
  • UK NEQAS, 2012
    The UK NEQAS for Molecular Genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation.

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center